Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.25 -0.25 (-7.14%)
As of: Oct 20, 2026 · 3:58 PM EDT

Apimeds Pharmaceuticals US (APUS) Assets (2023 - 2026)

Updated

Apimeds Pharmaceuticals US (APUS) reported Assets of $127.62 million for Q2 2026, compared with $10.55 million a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Apimeds Pharmaceuticals US posted Assets of $164.18 million.

  • By year, Assets came in at $13,057 in FY2024 (-96.9%) and $422,076 in FY2023.
  • Five-year quarterly Assets spans a low of $13,057 in Q4 2024 and a high of $164.18 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 201.06 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 135.12 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 115.83 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 201.13 Bn
10 Apimeds Pharmaceuticals US 5.65 Mn -13.98 Mn - 127.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.62 Mn
Dec 31, 2025 164.18 Mn
Sep 30, 2025 9.25 Mn
Jun 30, 2025 10.55 Mn
Mar 31, 2025 259,904.00
Dec 31, 2024 13,057.00
Dec 31, 2023 422,076.00
API Access

Apimeds Pharmaceuticals US Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=APUS&period=max&api_key=YOUR_API_KEY